Classification of Sudden and Arrhythmic Death

Since all death is (eventually) sudden and associated with cardiac arrhythmias, the concept of sudden death is only meaningful if it is unexpected, while arrhythmic death is only meaningful if life could have continued had the arrhythmia been prevented or treated. Current classifications of death as being arrhythmic or sudden are all biased by the difficulty of having to decide on the degree of unexpectedness or the likelihood that life could continue without the arrhythmia. The uncertainties are enlarged by the fact that critical data (such as knowledge of arrhythmias at the time of death or autopsy) are available in only a few percent of cases. A main problem in using classifications is the lack of validation data. This situation has, with the MADIT trial, changed in the case of the Thaler and Hinkle classification of arrhythmic death. The MADIT trial demonstrated that arrhythmic death was nearly abolished by the implantable defibrillator, indicating that arrhythmic death by this classification is meaningful, at least in the population studied. For future investigations, a call is made for committees to present data in a way that allows the reader to examine the quality of the data used for evaluation.

[1]  N Engl,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.

[2]  A. Hall,et al.  Mode of death in chronic heart failure. A request and proposition for more accurate classification. , 1996, European heart journal.

[3]  M Malik,et al.  Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction. , 1996, Journal of the American College of Cardiology.

[4]  Bertram Pitt,et al.  Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.

[5]  F. Venditti,et al.  Classification of death in antiarrhythmia trials. , 1996, Journal of the American College of Cardiology.

[6]  M. Schoenfeld,et al.  Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. , 1996, Circulation.

[7]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[8]  Richard P. Lewis,et al.  Guidelines for Clinical Intracardiac Electrophysiological and Catheter Ablation Procedures. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures). Developed , 1995, Circulation.

[9]  J. Demirovic,et al.  Epidemiology of sudden coronary death: an overview. , 1994, Progress in cardiovascular diseases.

[10]  A. Moss,et al.  Instantaneous cardiac death in the posthospital period after acute myocardial infarction. , 1992, The American journal of cardiology.

[11]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[12]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[13]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[14]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[15]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[16]  W. Kannel,et al.  Epidemiology of sudden coronary death: population at risk. , 1990, The Canadian journal of cardiology.

[17]  S. Goldstein Toward a new understanding of the mechanism and prevention of sudden death in coronary heart disease. , 1990, Circulation.

[18]  H. Greene,et al.  Sudden arrhythmic cardiac death--mechanisms, resuscitation and classification: the Seattle perspective. , 1990, The American journal of cardiology.

[19]  H L Greene,et al.  Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study). , 1989, The American journal of cardiology.

[20]  J. Fleiss,et al.  Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction. , 1988, The American journal of cardiology.

[21]  R. Myerburg Sudden cardiac death: epidemiology, causes, and mechanisms. , 1987, Cardiology.

[22]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[23]  W. Roberts Sudden cardiac death: definitions and causes. , 1986, The American journal of cardiology.

[24]  R. Byington,et al.  Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group. , 1984, Controlled clinical trials.

[25]  R. Hutchinson,et al.  Timing, mechanism and clinical setting of witnessed deaths in postmyocardial infarction patients. , 1984, Journal of the American College of Cardiology.

[26]  L E Hinkle,et al.  Clinical Classification of Cardiac Deaths , 1982, Circulation.

[27]  S. Goldstein The necessity of a uniform definition of sudden coronary death: witnessed death within 1 hour of the onset of acute symptoms. , 1982, American heart journal.

[28]  B. A.,et al.  Sudden Death , 1855, Developments in Cardiovascular Medicine.

[29]  The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group. , 1980, Circulation.

[30]  Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. , 1979, Circulation.

[31]  T. Killip Time, Place, Event of Sudden Death , 1975, Circulation.

[32]  M. Friedman,et al.  Instantaneous and sudden deaths. Clinical and pathological differentiation in coronary artery disease. , 1973, JAMA.

[33]  G. Biörck,et al.  “Sudden Death”‐What Are We Talking About? , 1972, Circulation.

[34]  C. J. Schwartz,et al.  On the pathological diagnosis of acute ischaemic heart disease. , 1972, Atherosclerosis.

[35]  M. Schatz,et al.  On Sudden Death , 1971, Circulation.

[36]  L. Kuller,et al.  AN EPIDEMIOLOGICAL STUDY OF SUDDEN AND UNEXPECTED DEATHS IN ADULTS , 1967, Medicine.

[37]  L. Kuller,et al.  Sudden and unexpected non-traumatic deaths in adults: a review of epidemiological and clinical studies. , 1966, Journal of chronic diseases.

[38]  G. Burch,et al.  Selected clues in cardiac auscultation. , 1962, American heart journal.